|
Status |
Public on Aug 05, 2015 |
Title |
Alzheimer, Mild Cognitive impairment and control samples from AddneuroMed Cohort (batch 2) |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Alzheimer case-control samples originate from the EU funded AddNeuroMed Cohort, which is a large cross-European AD biomarker study relying on human blood as the source of RNA.
|
|
|
Overall design |
The design is case-control. Cases are either Alzheimer's disease patients, subjects with mild cognitive impairment or age and gender matched controls.
|
|
|
Contributor(s) |
Hodges A, Howard R |
Citation(s) |
26343147 |
|
Submission date |
Nov 06, 2014 |
Last update date |
May 30, 2024 |
Contact name |
James Timmons |
E-mail(s) |
jamie@augurprecisionmedicine.com, jamie.timmons@gmail.com
|
Organization name |
Augur Precision Medicine LTD
|
Street address |
Bridge of Allan
|
City |
Stirling |
ZIP/Postal code |
FK9 4AX |
Country |
United Kingdom |
|
|
Platforms (1) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
Samples (388)
|
|
This SubSeries is part of SuperSeries: |
GSE63063 |
Alzheimer, Mild Cognitive impairment and control samples from AddneuroMed Cohort |
|
Relations |
BioProject |
PRJNA266530 |